Replay available

Perimeter Medical Imaging AI, Inc. (PINK) Q2 2025 Earnings Call

Perimeter Medical Imaging AI, Inc. (TSXV: PINK) Q2 2025 earnings conference call, held 2025-08-26. Replay captured from the company's public earnings webcast.

Tue, August 26, 2025 at 5:00 PMendedReplay
Perimeter Medical Imaging AI, Inc. (PINK) Q2 2025 Earnings Call

Hosted by

Featured presenters

Adrian Mendez

Chief Executive Officer

Sarah Bryant

Chief Financial Officer

Andrew Berkley

Chief Innovation Officer and Co-Founder

Stephen Kilmer

Investor Relations

Scott Macaulay

Analyst, Paradigm Capital

Doug Lowe

Analyst, Lead Financial

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Perimeter Medical Imaging Ai Inc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.111 -- 00:00:05.377 Good afternoon, ladies and gentlemen, and welcome to the Perimeter Medical second quarter 00:00:05.377 -- 00:00:10.925 2025 conference call. At this time, all lines are in listen-only mode. 00:00:10.925 -- 00:00:15.412 Following the presentation, we will conduct a question and answer session. 00:00:15.412 -- 00:00:19.818 If at any time during this call you require immediate assistance, please press door zero 00:00:19.818 -- 00:00:25.346 for the operator. This call is being recorded on Tuesday, August 26, 2025. 00:00:25.346 -- 00:00:30.133 I would now like to turn the conference over to Stephen Kilmer, Investor Relations. 00:00:30.133 -- 00:00:32.554 Please go ahead. 00:00:33.157 -- 00:00:35.760 Thank you. Good afternoon, everyone. 00:00:35.760 -- 00:00:39.824 Let me start by pointing out that this conference call will include forward-looking statements 00:00:39.824 -- 00:00:43.008 within the meaning of applicable securities laws. 00:00:43.008 -- 00:00:46.992 These may include statements regarding the future financial position, business strategy 00:00:46.992 -- 00:00:51.717 and strategic goals, commercial activities and timing, competitive conditions, research 00:00:51.717 -- 00:00:56.442 and development activities, projected costs and capital expenditures, research and clinical 00:00:56.442 -- 00:01:00.887 testing outcomes, the potential benefits of our products, including perimeter S-series 00:01:00.887 -- 00:01:06.123 OCT, perimeter B series OCT, and perimeter image assist, 00:01:06.123 -- 00:01:11.189 perimeter's ability to broaden its user base, and the expected approval of its proprietary 00:01:11.189 -- 00:01:12.711 AI, 00:01:12.711 -- 00:01:16.635 expectations regarding new products and the timing thereof, and expectations r...